Saccharomyces boulardii promoters for control of gene expression in vivo

Carmen Sands,Karl Alex Hedin,Ruben Vazquez-Uribe,Morten Otto Alexander Sommer
DOI: https://doi.org/10.1186/s12934-023-02288-8
IF: 6.352
2024-01-09
Microbial Cell Factories
Abstract:Interest in the use of engineered microbes to deliver therapeutic activities has increased in recent years. The probiotic yeast Saccharomyces boulardii has been investigated for production of therapeutics in the gastrointestinal tract. Well-characterised promoters are a prerequisite for robust therapeutic expression in the gut; however, S. boulardii promoters have not yet been thoroughly characterised in vitro and in vivo.
biotechnology & applied microbiology
What problem does this paper attempt to address?